Limonin alleviates imiquimod-induced psoriasis-like skin inflammation in mice model by downregulating inflammatory responses
Authors:
- 19 December 2024
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (6) , 6901-6914
Abstract
Psoriasis is a chronic inflammatory condition affecting 1–2% of the global population. Phytomedicine, which uses plant-based compounds, is emerging as a promising approach to managing such inflammatory diseases. Limonin, a phytochemical found in citrus fruits and known for its bitter taste, possesses significant pharmacological properties. In this study, we evaluated the anti-psoriatic effects of limonin using a psoriasis-induced mice model. BALB/c mice were treated with imiquimod to induce psoriasis and then administered limonin at doses of 20 and 40 mg/kg/day for 6 days. Tacrolimus ointment served as a positive control. We assessed the hematological profile to determine limonin’s impact on leukocytes in the psoriasis model. Additionally, histomorphometric analysis of ear and skin tissues was conducted to evaluate the therapeutic effects of limonin. We further investigated the antioxidant properties of limonin by measuring levels of antioxidants and oxidative stress markers. The anti-inflammatory effects were evaluated by quantifying inflammatory cytokines and signaling proteins. In vitro, the cytotoxicity and anti-inflammatory potential of limonin were assessed using murine macrophage RAW264.7 cells. Our findings showed that limonin significantly reduced leukocyte counts, decreased inflammatory cell infiltration, and improved skin histoarchitecture in psoriasis-induced mice. Limonin also effectively scavenged free radicals and reduced levels of inflammatory cytokines and proteins without causing cytotoxicity in RAW264.7 cells. Overall, our in vivo and in vitro results confirm that limonin is a potent anti-inflammatory agent that effectively ameliorates imiquimod-induced psoriasis. Graphical AbstractKeywords
This publication has 68 references indexed in Scilit:
- Association of enthesitis with severity of psoriasis in psoriatic arthritis: an observational studyRheumatology International, 2024
- Management of Psoriasis Patients with Serious Infectious DiseasesAdvances in Therapy, 2024
- Preparation and characterization of solid lipid nanoparticles encapsulated noscapine and evaluation of its protective effects against imiquimod-induced psoriasis-like skin lesionsBiomedicine & Pharmacotherapy, 2023
- Anti-psoriatic and anti-inflammatory effects of Kaempferia parviflora in keratinocytes and macrophage cellsBiomedicine & Pharmacotherapy, 2021
- Potential herbal constituents for psoriasis treatment as protective and effective therapyPhytotherapy Research, 2020
- Luteolin attenuates imiquimod–induced psoriasis-like skin lesions in BALB/c mice via suppression of inflammation responseBiomedicine & Pharmacotherapy, 2020
- Pathophysiology, Clinical Presentation, and Treatment of PsoriasisJAMA, 2020
- Comparison of Biologics and Oral Treatments for Plaque PsoriasisJAMA Dermatology, 2020
- IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligoArchives of Dermatological Research, 2016
- Resistin Up-Regulates COX-2 Expression via TAK1-IKK-NF-κB Signaling PathwayInflammation, 2009